Find a Tender · Free access
Leeds Teaching Hospitals NHS Trust
This Find a Tender notice and its original source links are free to access. Wallis Tenders is an independent service.
- Work location
- Location to check
- Published value
- £36,095,687 · Framework value — not guaranteed work
Excluding VAT; gross value also published - Closing date
- 30 Nov 2026, 12:00 GMT
- Notice date
- 23 Sep 2026
- Last checked
- 14 Nov 2026, 00:07 GMT
A specific delivery region is not confirmed. Check the work location in the original notice.
1 lot(s) listed. Check individual lot values and requirements at source.
The value can cover the full contract duration, not an annual payment.
Collected from an Open Contracting Partnership compiled snapshot. Earlier history may be incomplete.
Historical baseline; recent changes are being collected separately.
Published description
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.
Read the original notice for the full scope, requirements, closing time and latest changes. Registration may be required to access documents or apply.
View original notice ↗ Additional source ↗ Additional source ↗Notice history (8)
- 23 Sep 2026 · Future work
- 23 Sep 2026 · Future work
- 23 Sep 2026 · Future work
- 23 Sep 2026 · Future work
- 23 Sep 2026 · Notice updated
- 13 Oct 2026 · Opportunity published
- 13 Oct 2026 · Opportunity published
- 13 Oct 2026 · Notice updated